A clinical and molecular genetic study of hypophosphatemic rickets in children

Pediatric Research

Volumn 58, Issue 2, 2005, Pages 329-333

  Cho, Hee Y ^a   Lee, Bum H ^a   Kang, Ju H ^a   Ha, Il S ^a   Cheong, Hae Il ^a   Choi, Yong ^a  

^a Seoul National University Children's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; VITAMIN D;

ARTICLE; BONE DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FGF23 GENE; GENE; GENE DELETION; GENE MUTATION; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; INFANT; KIDNEY CALCIFICATION; KOREA; LABORATORY TEST; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PHEX GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; RENAL DIABETES; SEX RATIO; TREATMENT OUTCOME; VITAMIN D RESISTANT RICKETS;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE DELETION; GENOTYPE; GLYCOSURIA; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; INFANT; MALE; MUTATION; MUTATION, MISSENSE; PHENOTYPE; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHATES; POLYMERASE CHAIN REACTION; PROTEINS; VITAMIN D;

EID: 23244455513     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000169983.40758.7B     Document Type: Article

References (30)

1. Hanna JD, Niimi K, Chan JC 1991 X-linked hypophosphatemia. Genetic and clinical correlates. Am J Dis Child 145:865-870
2. Tenenhouse HS, Murer H 2003 Disorders of renal tubular phosphate transport. J Am Soc Nephrol 14:240-248
3. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO 2001 Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3889-3899
4. Drezner MK 2000 PHEX gene and hypophosphatemia. Kidney Int 57:9-18
5. Rowe PS 2000 The molecular background to hypophosphatemic rickets. Arch Dis Child 83:192-194
6. Quarles LD 2003 FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1-E9
7. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanish Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663
8. Strewler GJ 2001 FGF23, hypophosphatemia, and rickets: has phosphatonin been found? Proc Natl Acad Sci USA 98:5945-5946
9. Chan JC, Alon U, Hirschman GM 1985 Renal hypophosphatemic rickets. J Pediatr 106:533-544
10. Jan de Beur SM, Levine MA 2002 Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87:2467-2473
11. Bai X Y, Miao D, Goltzman D, Karaplis AC 2003 The autosomal dominant hypophosphatemic rickets RI76Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843-9849
12. White KE, Evans WE, O'Riordan JL, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM; the ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
13. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500-6505
14. Strom TM, Francis F, Lorenz B, Boddrich A, Econs MJ, Lehrach H, Meitinger T 1997 Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:165-171
15. Sabbagh Y, Boileau G, DesGroseillers L, Tenenhouse HS 2001 Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein. Hum Mol Genet 10:1539-1546
16. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD 2003 Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419-37426
17. Benet-Pagès A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM 2004 FGF23 is processed by proprotein convertases but not by PHEX. Bone 35:455-462
18. 3 production. J Biol Chem 278:2206-2211
19. Scriver CR, Tenenhouse HS 1992 X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage. J Inherit Metab Dis 15:610-624
20. Dixon PH, Christie PT, Wooding C, Trump D, Grieff M, Holm I, Gertner JM, Schmidtke J, Shah B, Shaw N, Smith C, Tau C, Schlessinger D, Whyte MP, Thakker RV 1998 Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab 83:3615-3623
21. Tyynismaa H, Kaitila I, Näntö-Salonen K, Ala-Houhala M, Alitalo T 2000 Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets. Hum Mutat 15:383-384
22. Christie PT, Harding B, Nesbit MA, Whyte MP, Thakker RV 2001 X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene. J Clin Endocrinol Metab 86:3840-3844
23. Popowska E, Pronicka E, Sulck A, Jurkiewicz D, Rowinska E, Sykut-Cegielska J, Rump Z, Arasimowicz E, Krajewska-Walasek M 2001 X-linked hypophosphatemia in Polish patients. 2. Analysis of clinical features and genotype-phenotype correlation. J Appl Genet 42:73-88
24. Muhlbauer RC, Fleisch H 1991 Abnormal renal glucose handling in X-linked hypophosphataemic mice. Clin Sci (Lond) 80:71-76
25. Baran DT, Hahn TJ, Avioli LV 1978 Effect of oral glucose ingestion on renal phosphate reabsorption and clearance in vitamin D-resistant rickets. J Clin Endocrinol Metab 47:138-144
26. Aubert J, Templier B, Lacour B, Clavel J, Ulmann A 1984 Modification in the renal phosphate handling after oral administration of glucose to conscious rats. Miner Electrolyte Metab 10:98-102
27. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M 1991 Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843-1848
28. Mughal Z 2002 Rickets in childhood. Semin Musculoskelet Radiol 6:183-190
29. Makitie O, Kooh SW, Sochett E 2003 Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol (Oxf) 58:163-168
30. Alon US, Monzavi R, Lilien M, Rasoulpour M, Geffner ME, Yadin O 2003 Hypertension in hypophosphatemic rickets-role of secondary hyperparathyroidism. Pediatr Nephrol 18:155-158